223 related articles for article (PubMed ID: 18586294)
21. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
22. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
23. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
Li Y; Li X; Stremlau M; Lee M; Sodroski J
J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
[TBL] [Abstract][Full Text] [Related]
24. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
[TBL] [Abstract][Full Text] [Related]
25. Unique features of TRIM5alpha among closely related human TRIM family members.
Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
[TBL] [Abstract][Full Text] [Related]
26. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
27. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.
Stremlau M; Perron M; Lee M; Li Y; Song B; Javanbakht H; Diaz-Griffero F; Anderson DJ; Sundquist WI; Sodroski J
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5514-9. PubMed ID: 16540544
[TBL] [Abstract][Full Text] [Related]
28. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
29. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
[TBL] [Abstract][Full Text] [Related]
30. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
Kutluay SB; Perez-Caballero D; Bieniasz PD
PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
[TBL] [Abstract][Full Text] [Related]
31. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
[TBL] [Abstract][Full Text] [Related]
32. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
[TBL] [Abstract][Full Text] [Related]
33. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.
White TE; Brandariz-Nuñez A; Valle-Casuso JC; Amie S; Nguyen L; Kim B; Brojatsch J; Diaz-Griffero F
Virology; 2013 Feb; 436(1):81-90. PubMed ID: 23158101
[TBL] [Abstract][Full Text] [Related]
34. Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.
Rahm N; Yap M; Snoeck J; Zoete V; Muñoz M; Radespiel U; Zimmermann E; Michielin O; Stoye JP; Ciuffi A; Telenti A
J Virol; 2011 May; 85(9):4173-83. PubMed ID: 21345948
[TBL] [Abstract][Full Text] [Related]
35. Hexagonal assembly of a restricting TRIM5alpha protein.
Ganser-Pornillos BK; Chandrasekaran V; Pornillos O; Sodroski JG; Sundquist WI; Yeager M
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):534-9. PubMed ID: 21187419
[TBL] [Abstract][Full Text] [Related]
36. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
37. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.
Diaz-Griffero F; Qin XR; Hayashi F; Kigawa T; Finzi A; Sarnak Z; Lienlaf M; Yokoyama S; Sodroski J
J Virol; 2009 Oct; 83(20):10737-51. PubMed ID: 19656869
[TBL] [Abstract][Full Text] [Related]
38. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Yap MW; Nisole S; Stoye JP
Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
[TBL] [Abstract][Full Text] [Related]
39. Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.
Maillard PV; Zoete V; Michielin O; Trono D
J Biol Chem; 2011 Mar; 286(10):8128-8140. PubMed ID: 21169362
[TBL] [Abstract][Full Text] [Related]
40. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
